|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,830,000 |
Market
Cap: |
4.45(B) |
Last
Volume: |
367,329 |
Avg
Vol: |
702,408 |
52
Week Range: |
$36.45 - $67.51 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 443 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
12,975 |
Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
39,197 |
39,329 |
Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,193,605 |
Total People Sold |
0 |
0 |
2 |
3 |
Total Sell Transactions |
0 |
0 |
5 |
6 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Joseph Jason |
SVP, General Counsel, Secy. |
|
2024-03-08 |
4 |
D |
$67.50 |
$270,000 |
D/D |
(4,000) |
94,006 |
|
- |
|
Joseph Jason |
SVP, General Counsel, Secy. |
|
2024-03-07 |
4 |
D |
$65.00 |
$586,010 |
D/D |
(9,000) |
98,006 |
|
- |
|
Nova Tina Susan |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$162,517 |
D/D |
2,465 |
6,069 |
|
- |
|
Casal Frank |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$237,546 |
D/D |
3,603 |
9,392 |
|
- |
|
Madaus Martin D |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$162,517 |
D/D |
2,465 |
2,465 |
|
- |
|
Rosenblatt Michael |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$162,517 |
D/D |
2,465 |
13,042 |
|
- |
|
Davis Robyn C |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$162,517 |
D/D |
2,465 |
29,587 |
|
- |
|
Mclaughlin Erica |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$162,517 |
D/D |
2,465 |
12,818 |
|
- |
|
Bousa Edward Peter |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$162,517 |
D/D |
2,465 |
2,465 |
|
- |
|
Hirsch Didier |
|
|
2024-02-12 |
4 |
A |
$65.93 |
$162,517 |
D/D |
2,465 |
2,465 |
|
- |
|
Zhou Ginger |
SVP and General Manager, Genom |
|
2024-02-01 |
4 |
A |
$39.41 |
$17,656 |
D/D |
448 |
12,942 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2024-02-01 |
4 |
A |
$39.41 |
$12,769 |
D/D |
324 |
31,287 |
|
- |
|
Hughes Violetta |
VP, Chief Accounting Officer |
|
2024-01-31 |
4 |
A |
$65.20 |
$20,277 |
D/D |
311 |
3,746 |
|
- |
|
Vacha Robin |
SVP, GM Life Science Products |
|
2023-12-05 |
4 |
D |
$56.60 |
$292,905 |
D/D |
(5,175) |
25,788 |
|
- |
|
Wang David Dong |
SVP & GM, SMS |
|
2023-12-01 |
4 |
D |
$57.96 |
$7,998 |
D/D |
(138) |
9,478 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2023-11-17 |
4 |
D |
$54.83 |
$283,965 |
D/D |
(5,179) |
74,868 |
|
- |
|
Pirogova Olga |
SVP and CHRO |
|
2023-11-16 |
4 |
A |
$54.57 |
$175,006 |
D/D |
3,207 |
3,207 |
|
- |
|
Robertson Lindon G |
EVP & Chief Financial Officer |
|
2023-11-16 |
4 |
D |
$53.81 |
$149,538 |
D/D |
(2,779) |
121,081 |
|
- |
|
Wang David Dong |
SVP & GM, SMS |
|
2023-11-16 |
4 |
A |
$54.57 |
$175,006 |
D/D |
3,207 |
9,616 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2023-11-16 |
4 |
A |
$54.57 |
$125,020 |
D/D |
2,291 |
80,047 |
|
- |
|
Gray David C |
Chief Strategy & New Business |
|
2023-11-16 |
4 |
D |
$53.81 |
$116,283 |
D/D |
(2,161) |
77,756 |
|
- |
|
Cueto Herman |
EVP, Chief Financial Officer |
|
2023-11-16 |
4 |
A |
$54.57 |
$812,547 |
D/D |
14,890 |
14,890 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2023-11-16 |
4 |
A |
$54.57 |
$1,224,987 |
D/D |
22,448 |
446,536 |
|
- |
|
Schwartz Stephen S |
CEO |
|
2023-11-16 |
4 |
D |
$53.81 |
$692,266 |
D/D |
(12,865) |
424,088 |
|
- |
|
Zhou Ginger |
SVP and General Manager, Genom |
|
2023-11-16 |
4 |
A |
$54.57 |
$175,006 |
D/D |
3,207 |
12,494 |
|
- |
|
1053 Records found
|
|
Page 1 of 43 |
|
|